News

Pharmabiz19h
AB Science receives several European countries approval to initiate the confirmatory phase 3 study of masitinib in ALS
AB Science receives several European countries approval to initiate the confirmatory phase 3 study of masitinib in ALS: Paris Saturday, July 26, 2025, 18:00 Hrs [IST] AB Science S ...
Pharmabiz23h
Applied DNA receives new follow-on LineaDNA order from global IVD manufacturer for use in cancer diagnostic application
Applied DNA receives new follow-on LineaDNA order from global IVD manufacturer for use in cancer diagnostic application: Stony Brook, New York Saturday, July 26, 2025, 14:00 Hrs [ ...
Pharmabiz23h
EMA Paediatric Committee elects Sabine Scherer as its new chair
EMA Paediatric Committee elects Sabine Scherer as its new chair: Amsterdam, The Netherlands Saturday, July 26, 2025, 13:30 Hrs [IST] At its July 2025 meeting, EMA’s Paediatric C ...
Pharmabiz21h
Xenetic Biosciences expands R&D collaboration with The Scripps Research Institute to advance DNase platform
Xenetic Biosciences expands R&D collaboration with The Scripps Research Institute to advance DNase platform: Framingham, Massachusetts Saturday, July 26, 2025, 16:00 Hrs [IST] Xen ...
Pharmabiz22h
US FDA approves LEO Pharma’s Anzupgo cream for the treatment of moderate-to-severe chronic hand eczema
Ballerup, Denmark Saturday, July 26, 2025, 15:00 Hrs [IST] ...